- Home
- SOWG vs IBIO Comparison
SOWG vs IBIO Comparison
Compare SOWG & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOWG
- IBIO
- Stock Information
- Founded
- SOWG 2010
- IBIO 2008
- Country
- SOWG United States
- IBIO United States
- Employees
- SOWG N/A
- IBIO N/A
- Industry
- SOWG Packaged Foods
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SOWG Consumer Staples
- IBIO Health Care
- Exchange
- SOWG Nasdaq
- IBIO Nasdaq
- Market Cap
- SOWG 10.7M
- IBIO 11.9M
- IPO Year
- SOWG N/A
- IBIO N/A
- Fundamental
- Price
- SOWG $0.69
- IBIO $0.79
- Analyst Decision
- SOWG
- IBIO Strong Buy
- Analyst Count
- SOWG 0
- IBIO 2
- Target Price
- SOWG N/A
- IBIO $5.50
- AVG Volume (30 Days)
- SOWG 339.2K
- IBIO 723.2K
- Earning Date
- SOWG 08-14-2025
- IBIO 09-19-2025
- Dividend Yield
- SOWG N/A
- IBIO N/A
- EPS Growth
- SOWG N/A
- IBIO N/A
- EPS
- SOWG N/A
- IBIO N/A
- Revenue
- SOWG $9,271,376.00
- IBIO $375,000.00
- Revenue This Year
- SOWG $6.81
- IBIO $81.33
- Revenue Next Year
- SOWG N/A
- IBIO N/A
- P/E Ratio
- SOWG N/A
- IBIO N/A
- Revenue Growth
- SOWG N/A
- IBIO 650.00
- 52 Week Low
- SOWG $0.51
- IBIO $0.56
- 52 Week High
- SOWG $14.96
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- SOWG 42.44
- IBIO 60.85
- Support Level
- SOWG $0.51
- IBIO $0.67
- Resistance Level
- SOWG $1.05
- IBIO $0.81
- Average True Range (ATR)
- SOWG 0.12
- IBIO 0.07
- MACD
- SOWG -0.03
- IBIO 0.02
- Stochastic Oscillator
- SOWG 32.59
- IBIO 89.29
About SOWG Sow Good Inc. Common Stock
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.